Outcomes of a Standardized, High-Caloric, Inpatient Re-Alimentation Treatment Protocol in 120 Severely Malnourished Adolescents with Anorexia Nervosa.

eating disorders energy intake nutrition refeeding syndrome

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
05 May 2022
Historique:
received: 17 03 2022
revised: 25 04 2022
accepted: 27 04 2022
entrez: 14 5 2022
pubmed: 15 5 2022
medline: 15 5 2022
Statut: epublish

Résumé

Evidence accumulates that, with close medical monitoring and phosphate supplementation, higher-caloric re-alimentation protocols beginning at 2000 kcal/day (HCR) are not associated with an increased incidence of electrolyte abnormalities in patients with anorexia nervosa (AN) but rather result in faster weight gain. These studies are still scant and have largely been performed in adults or moderately malnourished adolescents. Methods: A retrospective chart review of patients with AN aged 12−20 years and with a body mass index (BMI) < 15 kg/m2 alimented according to a standardized treatment protocol in a German clinic specialized in AN was conducted. All patients received 2000 kcal/day from day one. The effect of HCR was examined with respect to laboratory changes and weight development over 4 weeks. Results: In 120 youth (119 (99.2%) females and 1 (0.8%) male, the mean BMI was 13.1 ± 1.1 (range = 10.2−15.0), %mBMI was 62.1 ± 6.0% and weight gain was 0.76 ± 0.22 kg per week, with the highest rate of weight gain during week 1 (1.25 ± 1.28 kg/week). Over 4 weeks, the total weight gain was 3.00 ± 1.92 kg. Nine patients (7.5%) developed mild hypophosphatemia, and none developed refeeding syndrome. Conclusions: Starting re-alimentation with 2000 kcal/d under close medical surveillance, severely malnourished youth with AN met the recommended weight gain targets between 0.5 and 1 kg/week according to current treatment guidelines, without anyone developing refeeding syndrome.

Identifiants

pubmed: 35566710
pii: jcm11092585
doi: 10.3390/jcm11092585
pmc: PMC9105338
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK063720
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK098722
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD082166
Pays : United States

Références

BMC Psychiatry. 2013 Nov 07;13:290
pubmed: 24200367
Mymensingh Med J. 2022 Jan;31(1):258-262
pubmed: 34999712
Eat Behav. 2016 Apr;21:172-8
pubmed: 26970731
J Am Diet Assoc. 2006 Dec;106(12):2073-82
pubmed: 17186637
J Adolesc Health. 2013 Nov;53(5):579-84
pubmed: 24054812
JAMA Pediatr. 2021 Jan 1;175(1):19-27
pubmed: 33074282
J Adolesc Health. 2013 Nov;53(5):573-8
pubmed: 23830088
Nutrients. 2022 Jan 05;14(1):
pubmed: 35011105
J Adolesc Health. 2010 Jun;46(6):577-82
pubmed: 20472215
J Nutr Metab. 2016;2016:5168978
pubmed: 27293884
J Adolesc Health. 2012 Jan;50(1):24-9
pubmed: 22188830
Curr Opin Pediatr. 2011 Aug;23(4):390-4
pubmed: 21670680
J Eat Disord. 2016 Dec 19;4:35
pubmed: 28018595
J Eat Disord. 2015 Mar 25;3:8
pubmed: 25830024
Nutr Clin Pract. 2022 Apr;37(2):470-478
pubmed: 34494697
Eur Eat Disord Rev. 2021 Mar;29(2):165-177
pubmed: 33230832
Int J Eat Disord. 2015 Nov;48(7):866-73
pubmed: 25625572
Nutr Clin Pract. 2013 Jun;28(3):358-64
pubmed: 23459608
J Adolesc Health. 2003 Jan;32(1):83-8
pubmed: 12507806
Int J Eat Disord. 2000 Sep;28(2):181-7
pubmed: 10897080
Am J Psychiatry. 2000 Jan;157(1 Suppl):1-39
pubmed: 10642782
Eur J Clin Nutr. 2018 Mar;72(3):428-435
pubmed: 29167575
JPEN J Parenter Enteral Nutr. 2012 May;36(3):275-83
pubmed: 22535923
BMJ Open. 2013 Jan 11;3(1):
pubmed: 23315514
Arch Biochem Biophys. 1952 Sep;40(1):1-12
pubmed: 12997182
J Adolesc Health. 2016 Jun;58(6):616-20
pubmed: 26774639
BMJ. 2008 Jun 28;336(7659):1495-8
pubmed: 18583681
J Clin Med. 2020 May 19;9(5):
pubmed: 32438760
J Adolesc Health. 2014 Sep;55(3):455-7
pubmed: 25151056

Auteurs

Sophia Dalenbrook (S)

Department of Child and Adolescent Psychiatry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 3, 13353 Berlin, Germany.

Silke Naab (S)

Schoen Clinic Roseneck, Prien am Chiemsee, 83209 Prien am Chiemsee, Germany.

Andrea K Garber (AK)

Division of Adolescent and Young Adult Medicine, Department of Pediatrics, University of California, San Francisco, CA 94143, USA.

Christoph U Correll (CU)

Department of Child and Adolescent Psychiatry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 3, 13353 Berlin, Germany.
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY 11549, USA.
Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY 11004, USA.

Ulrich Voderholzer (U)

Schoen Clinic Roseneck, Prien am Chiemsee, 83209 Prien am Chiemsee, Germany.
Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximillians Universität München, 80539 Munich, Germany.
Department of Psychiatry and Psychotherapy, University Hospital of Freiburg, 79106 Freiburg, Germany.

Verena Haas (V)

Department of Child and Adolescent Psychiatry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 3, 13353 Berlin, Germany.

Classifications MeSH